CODIAK BIOSCIENCES INC (CDAK)
US1920101060 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to CDAK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 16005.26% above the current price.
CDAK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CDAK.
In the previous month the buy percentage consensus was at a similar level.
CDAK was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-07 | Goldman Sachs | Maintains | Neutral |
| 2022-09-01 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-07-05 | Goldman Sachs | Maintains | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-02-22 | Wedbush | Maintains | Outperform |
| 2022-02-11 | Goldman Sachs | Initiate | Buy |